XT-150

N/A

Report date: 2024/09/19 15:03:46

Base Information

Drug NameXT-150
Drug Alias NameIL-10 transgene plasmid DNA (Xalud Therapeutics)XT-101XT-150XT-101-R
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionInterleukin-10 gene transference
TargetsInterleukin-10
Therapy Area/IndicationsBack PainInflammationNeuralgia +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXalud Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesXalud Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsBack PainInflammationAmyotrophic Lateral Sclerosis +[6] 
Inactive IndicationsNeuralgiaOsteoarthritis, Spine

Other Information

ATC CodeN/A
Related LinksN/A